April 2010

|
Volume 22 Issue 4
Vascular closure devices (VCDs) became available to the interventional cardiology community in the mid-1990s. VCDs were initially created to treat the high rates of access-site bleeding associated with percutaneous coronary intervention (PCI) procedu…
Vascular Complications after Percutaneous Coronary Intervention Following Hemostasis with the Mynx Vascular Closure Device Versus the AngioSeal Vascular Closure Device ABSTRACT: We investigated the prevalence of vascular complications after PCI fol…
In this issue of the Journal, Ussia and colleagues discuss their experience with using balloon aortic valvuloplasty (BAV) as a “bridge” to transcatheter aortic valve implantation (TAVI) in patients at high risk for TAVI.1 They chose high-risk patient…
ABSTRACT: Objectives. To provide data on feasibility, safety and efficacy of balloon aortic valvuloplasty (BAV) as a bridge to trans-catheter aortic valve implantation (TAVI). Background. There are no data on BAV use as a bridge to TAVI in patients…
In the past few years, the use of drug-eluting stents (DES) has had a significant impact on the practice of interventional cardiology. The introduction of DES followed the same course as any newly introduced technique, with the initial period of enth…
Drug-Eluting Stents versus Bare-Metal Stents in Acute ST-Segment Elevation Myocardial Infarction. A Single-Center Experience with Long-Term Follow Up ABSTRACT: Objectives. To compare the efficacy and safety of drug-eluting stents (DES) vs. bare-me…